DOI: 10.1055/s-00035024

Thrombosis and Haemostasis


Buller HR, Lensing AW, Prins MH. et al.
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.

Blood 2008;
112: 2242-2247.

Download Bibliographical Data

Search in: